We invest early in deep tech and bioscience companies, often investing time ahead of capital. Our focus is investing at the pre-seed and seed stages, but we have also invested at the founding stage for certain teams.
We look for entrepreneurs innovating in health, biological platforms, and applied robotics, as well as those that are creating entirely new industries.
Diagnostics & testing — Genomic medicine applications — Devices and treatments for long-term illness and disease —Drug discovery platforms & tools — Preventative screening — Health devices & platforms — Vaccine development & deployment
Applications across food, health, and materials — Gene circuits & protein engineering — Enzyme platforms & DNA synthesis — Protein alternatives & new ingredients — Ag platforms & tools — Restructuring food supply chains
Robotics & advanced manufacutring applications — Gene therapy and cell therapy manufacturing — Soft robotics — Biomanufacturing — Software-enabled manufacturing & biomanufacturing tools & services — Supply chain resilience & agile reshoring